• SENSEX 74,529.08
    -329.91 (--0.44%)
  • BANKNIFTY 56,215.55
    -255.10 (--0.45%)
  • Pine Labs
    205.00 283.70(%)
  • HDFC Bank
    738.70 682.00(%)
  • Meesho
    244.80 254.65(%)
  • Glass Wall Syst.
    318.00 318.00(%)
  • Cholaman.Inv.&Fn
    1,756.50 1,299.80(%)
  • Solar Industries
    20,243.65 22,630.05(%)
  • Cupid
    265.35 298.95(%)
  • Aster DM Quality
    746.55 519.80(%)
  • Protean eGov
    656.45 940.00(%)
  • Gabriel India
    1,495.35 1,600.00(%)
  • Nippon ETF Liq.
    999.99 978.01(%)
  • Transrail Light
    487.90 800.35(%)
  • Reliance Industries
    1,237.80 1,232.35(%)
  • JSW Dulux
    3,131.20 2,649.05(%)
  • Kaynes Tech
    3,427.35 2,995.85(%)
  • Apar Inds.
    17,916.55 6,800.00(%)
  • Titan Company
    4,983.70 5,187.45(%)
  • Dixon Technolog.
    12,997.00 9,605.05(%)
  • Eternal
    341.80 368.40(%)
  • Larsen & Toubro
    3,867.50 3,288.65(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Auro Laboratories Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 4899.0
  • ISIN : INE292C01011
251.15 1 (0.42%)
  • As on 23 Sep 2026 (EOD)

  • Today’s Low

    247.10

  • Today’s High

    263.00

  • Open

    259.00

  • Perv Close

    250.10

  • 52W Low

    159.00

  • 52W High

    317.00

Key Indicators

  • P/E(TTM)

    32.74

  • Mar.Cap (₹Cr.)

    156.53

  • Div & Yield %

    0.00

  • Book Value(₹)

    74.36

  • Debt-Equity Ratio

    0.42

  • AGM Date

    22-Sep-2026

  • EPS

    7.67

  • P/E Ratio

    32.74

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    156.53

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    6.23

  • BV (₹)

    74.40

  • Sales( ₹ in Cr.)

    30.74

  • NP (in Cr.)

    3.79

  • NP Var(%)

    106.0

  • Div%

    0.0

  • CPS (₹)

    10.60

  • EPS (₹)

    6.10

  • Traded Value (₹ in Lakhs)

    156.53

  • 52 Week High

    317.00

  • 52 Week Low

    159.00

  • Price BSE

    251.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    156.53

  • P/C Ratio

    23.70

  • P/E Ratio

    41.30

  • Price Vs.BV

    6.10

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 30.74 19.12 53.64 52.89 50.87 54.25
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 30.74 19.12 53.64 52.89 50.87 54.25
Other Income 2.01 0.93 1.50 0.94 1.09 0.76
Stock Adjustments 8.23 -4.13 2.48 1.61 0.98 -0.91
Total Income 40.98 15.92 57.62 55.44 52.94 54.10
EXPENDITURE :            
Raw Materials 14.29 5.08 29.04 37.30 33.76 27.64
Power and Fuel Cost 1.85 0.33 2.43 2.08 1.67 1.60
Employee Cost 5.86 2.47 3.91 3.76 3.70 3.64
Other Manufacturing Expenses 0.42 0.10 0.56 1.42 1.76 2.10
Selling and Administration Expenses 5.44 2.89 7.91 4.73 5.86 5.84
Miscellaneous Expenses 1.25 1.01 1.60 0.82 0.48 1.29
Employee Benefit Expenses 5.86 2.47 3.91 3.76 3.70 3.64
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 29.11 11.87 45.45 50.11 47.22 42.10
Operating Profit 11.87 4.06 12.18 5.33 5.72 12.00
Interest 4.25 1.08 0.74 0.81 0.83 0.46
Gross Profit 7.62 2.98 11.44 4.52 4.89 11.54
Depreciation 2.81 1.10 1.09 1.07 1.02 1.04
Profit Before Tax 4.81 1.88 10.35 3.45 3.87 10.50
Current Tax 0.00 0.10 2.74 1.00 1.07 3.20
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 1.28 -0.06 -0.19 0.00 -0.04 0.12
Reported Net Profit 3.53 1.84 7.79 2.44 2.84 7.18
Extraordinary Items -0.26 0.00 0.00 0.00 0.00 0.00
Adjusted Net Profit 3.79 1.84 7.79 2.44 2.84 7.18
Adjustment below Net Profit 0.00 -0.95 -0.03 0.24 0.09 -0.09
P & L Balance brought forward 35.95 35.06 27.30 24.62 21.68 14.60
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 39.48 35.95 35.06 27.30 24.62 21.68
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 5.67 2.95 12.50 3.92 4.56 11.52
Earnings Per Share(Adj)-Unit Curr 5.67 2.95 12.50 3.92 4.56 11.52
Book Value 74.36 68.94 67.32 54.87 50.58 45.86
Book Value(Adj)-Unit Curr 74.36 68.94 67.32 54.87 50.58 45.86

Shareholding Pattern

  • Promoter Group

    52.41%

  • Public Share Holding

    47.60%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 1,183,013 18.98 1,183,013 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 2,083,126 33.42 2,083,126 5
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 3,266,139 52.41 3,266,139 6
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 400 0.01 0 1
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 400 0.01 0 1
2] Non Institution
Bodies Corporate 77,397 1.24 64,897 27
Clearing Members 7,673 0.12 7,673 6
Directors of their Relatives 10 0.00 10 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 384,561 6.17 239,861 223
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 53,767 0.86 53,267 72
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 412,197 6.61 412,197 8
Individuals holding nominal share capital up to Rs. 1 lakh 1,866,693 29.95 1,339,725 7,962
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 157,206 2.52 157,206 5
Sub Total 2,965,961 47.59 2,281,293 8,308
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 6,232,500 100.00 5,547,432 8,315

Company Background

Auro Laboratories LtdPharmaceuticals - Indian - Bulk Drugs

  • Auro Laboratories Ltd
  • BSE Code : 4899.0
  • ISIN : INE292C01011

  • Incorporation Year

    1989

  • Registered Office

    K-56 MIDC Indl Area
    Tarapur Boisar, Thane,
    Maharashtra-401506

  • Telephone

    91-22-66635456

  • FAX

  • Chairman

    Sharat Deorah

  • Managing Director

  • Company Secretary

    Padma Tapariya

  • Auditor

    B L Dasharda & Associates

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Purva Sharegistry (I) Pvt Ltd
    9 ShivShakti Indl Es,
    J R Boricha Marg,Lower Parel
    Mumbai - Mumbai - 400 011

Auro Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Auro Labs. 251.15 32.75 30.74 33.40 9.16
Abbott India 27,223.20 7,217.19 6,929.05 35.83 43.78
Astrazeneca Phar 6,712.15 2,304.07 2,275.58 98.93 27.86
Glaxosmi. Pharma 2,871.50 3,932.76 3,790.20 45.87 58.17
Novartis India 1,976.65 393.10 354.33 49.92 15.94
Cipla 1,381.00 20,102.60 18,979.95 36.29 13.88
Bliss GVS Pharma 690.40 773.53 729.81 64.16 12.51
Amrutanjan Healt 500.25 520.13 502.55 26.79 24.16
Fermenta Biotec. 471.40 474.15 450.25 22.01 18.77
Guj. Themis Bio. 411.75 168.25 165.82 110.09 18.05
Ambalal Sarabhai 38.82 19.52 3.94 71.89 6.77